Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Tandem Meetings 2023 | Association of cytopenia with survival in patients with B-cell lymphoma treated with CAR-T therapy

Nausheen Ahmed • 20 Feb 2023
Tandem Meetings 2023
B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma CAR-T Eltrombopag

Nausheen Ahmed, MD, University of Kansas Medical Center, Westwood, KS, comments on the association between cytopenia at day 90 and survival in patients with B-cell malignancies treated with CAR-T therapy, highlighting potential strategies to manage this side effect. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

BMS: Advisory Board; KUMC – Kite Pharma: Research Funding

More from Nausheen Ahmed

1:18
Addressing disparities in access to CAR-T therapy for hematological malignancies
Nausheen Ahmed • 9 Jun 2023
0:47
Outcomes of outpatient tisa-cel recipients with B-NHL
Nausheen Ahmed • 9 Jun 2023
1:06
Exploring the role of CAR-T therapy in MCL & impact of prior treatment with BTKi or bendamustine
Nausheen Ahmed • 9 Jun 2023
0:47
Real-world outcomes of brexu-cel in patients with R/R MCL
Nausheen Ahmed • 9 Jun 2023

Related Videos

1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
1:37
Exciting CAR-T clinical trials in LBCL and FL
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals